According to a new report, published by KBV research, The Global Lactase Market size is expected to reach $355.2 Million by 2028, rising at a market growth of 6.5% CAGR during the forecast period.
The Pharmaceutical Products & Dietary Supplements segment is showcasing a CAGR of 9.2% during (2022 - 2028). Lactose is utilized as an excipient in the pharmaceutical industry to bind tablets. As a result, dry lactase powder is employed to dissolve the sugar and transform it into a form that is suitable for eating by those who are lactose intolerant. Similarly, lactose-free dietary supplements deliver all the nutrients from milk without sacrificing the product's quality and flavor.
The Yeast segment acquired maximum revenue share in the Global Lactase Market by Source in 2021 thereby, achieving a market value of $189.3 Million by 2028. Traditionally, yeast has been used to extract lactase enzymes, which are stable enough to be used in pharmaceuticals and food and beverage applications. The U.S. Food and Drug Administration classifies lactose-fermenting yeasts as generally recognized as safe (GRAS) chemicals or substances, including Guehomyces pullulans and Kluyveromyces marxianus. As a result, lactase made from yeast is frequently utilized to make high-quality food, drink, and nutritional supplement items.
The Dry segment has shown the growth rate of 8.9% during (2022 - 2028). The dry formulation is more convenient and more concentrated. Since pH and temperature variations can affect enzymes greatly, it's critical to ensure ideal storage conditions. The growth of the segment is owed to the simplicity of this form as in necessary formulas pharmaceutical manufacturers primarily use dry forms. For the most part, businesses offer lactase mostly in dry form for export and import.
The North America market dominated the Global Lactase Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $120.7 Million by 2028. The Europe market is exhibiting a CAGR of 6.3% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/lactase-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
By Application
By Source
By Form
By Geography
Companies Profiled
Unique Offerings 
